VKH
CRBP icon

Virtu KCG Holdings’s Corbus Pharmaceuticals CRBP Stock Holding History

Virtu KCG Holdings’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-4,707
Closed -$1.17M – 2956
2017
Q1 		$1.17M Buy
4,707
+4,303
+1,065% +$1.06M 0.03% 596
2016
Q4 		$102K Buy
+404
New +$92.6K ﹤0.01% 2905
2015
Q4 		– Sell
-896
Closed -$42K – 3535
2015
Q3 		$42K Sell
896
-22
-2% -$1.47K ﹤0.01% 3028
2015
Q2 		$85K Buy
+918
New +$92.3K ﹤0.01% 2955

Other funds holding CRBP

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Virtu KCG Holdings's CRBP Position: Q2 2017 in Review

Virtu KCG Holdings sold out of Corbus Pharmaceuticals (CRBP) in Q2 2017, closing a stake of 4,707 shares — an estimated $1.17M sold.

Virtu KCG Holdings first reported a position in CRBP in Q2 2015 and held it in 4 quarters. The position peaked at $1.17M in Q1 2017. 69 funds tracked by Wall St. Rank hold CRBP as of Q2 2017.

  • Virtu KCG Holdings reported no remaining Corbus Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 4,707 Corbus Pharmaceuticals shares in Q2 2017, an estimated $1.17M.
  • Virtu KCG Holdings first reported a position in Corbus Pharmaceuticals in Q2 2015 and held it in 4 quarters.
  • Virtu KCG Holdings's Corbus Pharmaceuticals position peaked at $1.17M in Q1 2017.
  • 69 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.